Marcus Westerberg
Impact in
- Pharmaceutical Science top 2%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
-
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Diagnosis and Treatment 20
- Prostate Cancer Treatment and Research 19
- Oncology 13
- Colorectal Cancer Screening and Detection 7
- Global Cancer Incidence and Screening 7
- Co-authors
- Christer Nyström (5 shared papers)Hans Garmo (22 shared papers)Pär Stattin (18 shared papers)Bert Jonsson (1 shared paper)David Robinson (8 shared papers)Rolf Gedeborg (12 shared papers)Peter Nilsson (1 shared paper)Lars Holmberg (8 shared papers)
- Journals
- International Journal of Pharmaceutics (4 papers)JAMA Network Open (3 papers)PLoS ONE (3 papers)Journal of Clinical Epidemiology (2 papers)JNCI Cancer Spectrum (2 papers)
- Partner nations
- SwedenUnited KingdomUnited States
In The Last Decade
Marcus Westerberg
35 papers receiving 354 citations
Peers
Comparison fields: 5 of 70
- Pharmaceutical Science 147
- Pulmonary and Respiratory Medicine 170
- Oncology 95
- Analytical Chemistry 23
- Statistics and Probability 19
Countries citing papers authored by Marcus Westerberg
This map shows the geographic impact of Marcus Westerberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marcus Westerberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marcus Westerberg more than expected).
Fields of papers citing papers by Marcus Westerberg
This network shows the impact of papers produced by Marcus Westerberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marcus Westerberg. The network helps show where Marcus Westerberg may publish in the future.
Co-authors
The 25 scholars most cited alongside Marcus Westerberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 39 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1986 | 70 | |
| 2 | 1986 | 45 | |
| 3 | 2021 | 27 | |
| 4 | 1993 | 24 | |
| 5 | 1988 | 21 | |
| 6 | 2020 | 20 | |
| 7 | 2023 | 17 | |
| 8 | 2016 | 17 | |
| 9 | 2024 | 14 | |
| 10 | 2019 | 14 | |
| 11 | 2022 | 12 | |
| 12 | 2022 | 11 | |
| 13 | 2024 | 11 | |
| 14 | 1991 | 11 | |
| 15 | 2020 | 9 | |
| 16 | 2022 | 9 | |
| 17 | 2024 | 6 | |
| 18 | 2021 | 6 | |
| 19 | 2024 | 5 | |
| 20 | 2022 | 3 |
About Marcus Westerberg
Marcus Westerberg is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Pharmaceutical Science and Economics and Econometrics, having authored 39 papers that have together received 374 indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (20 papers), Prostate Cancer Treatment and Research (19 papers), Colorectal Cancer Screening and Detection (7 papers), Global Cancer Incidence and Screening (7 papers), Bladder and Urothelial Cancer Treatments (6 papers), Drug Solubulity and Delivery Systems (5 papers), Statistical Methods in Clinical Trials (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). The work is most often cited by research in Pharmaceutical Science (147 citations), Pulmonary and Respiratory Medicine (170 citations), Oncology (95 citations), Analytical Chemistry (23 citations) and Statistics and Probability (19 citations). Marcus Westerberg has collaborated with scholars based in Sweden, United Kingdom and United States. Frequent co-authors include Christer Nyström, Hans Garmo, Pär Stattin, Bert Jonsson, David Robinson, Rolf Gedeborg, Peter Nilsson, Lars Holmberg, Anna Bill‐Axelson and Ingela Franck Lissbrant. Their work appears in journals such as International Journal of Pharmaceutics, JAMA Network Open, PLoS ONE, Journal of Clinical Epidemiology and JNCI Cancer Spectrum.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.